top of page

MENU

PURMX Therapeutics Selected as an Awardee of the Japan Smart Healthy Aging QuickFire Challenge

  • 執筆者の写真: tomokokikuchi4
    tomokokikuchi4
  • 10月28日
  • 読了時間: 1分

PURMX Therapeutics, Inc. (Headquarters: Hiroshima-city, Hiroshima; President & CEO: Hidetoshi Tahara) is pleased to announce that it has been selected as an awardee of Johnson & Johnson’s Japan Smart Healthy Aging QuickFire Challenge.


This challenge invited Japan-based innovators, and those from across the globe working on Japan-focused innovations, to submit promising science or technologies that aim to potentially increase healthy life expectancy – to help people live longer, happier lives.

Awardees receive grant funding, virtual access to the Johnson & Johnson Innovation Asia Pacific ecosystem for one year, and mentorship from experts across Johnson & Johnson.


 The award ceremony was held on June 25, 2025, during the Japan Health Conference at INTEX Osaka. The event brought together healthcare innovators from Japan and abroad, and PURMX Therapeutics had the opportunity to showcase its technology and vision.




 
 
 

最新記事

すべて表示
米国FDAよりmiR-3140-3pの希少疾病用医薬品指定を取得

株式会社PURMX Therapeutics(以下、PURMX)(本社:広島県広島市、代表取締役社長:田原栄俊)は、現在、PURMXが臨床開発中のヒトの天然型核酸の⼀種であるマイクロRNAのmiR-3140-3pについて、2025年5月6日付で米国食品医薬品局(FDA)より...

 
 
 

コメント


bottom of page